NEOS Investment Management LLC Acquires 4,684 Shares of CME Group Inc. $CME

NEOS Investment Management LLC lifted its holdings in CME Group Inc. (NASDAQ:CME) by 8.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,567 shares of the financial services provider’s stock after purchasing an additional 4,684 shares during the quarter. NEOS Investment Management LLC’s holdings in CME Group were worth $12,933,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AXQ Capital LP purchased a new stake in shares of CME Group during the 2nd quarter valued at about $3,390,000. Waycross Investment Management Co bought a new position in CME Group during the second quarter valued at approximately $1,034,000. Nykredit A S bought a new position in CME Group during the second quarter valued at approximately $34,092,000. B. Metzler seel. Sohn & Co. AG boosted its holdings in CME Group by 69.4% in the second quarter. B. Metzler seel. Sohn & Co. AG now owns 35,192 shares of the financial services provider’s stock worth $7,771,000 after purchasing an additional 14,418 shares during the last quarter. Finally, PYA Waltman Capital LLC bought a new stake in CME Group in the 2nd quarter worth approximately $2,571,000. 87.75% of the stock is owned by institutional investors.

CME Group Trading Down 0.3%

Shares of CME Group stock opened at $281.29 on Friday. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company’s fifty day simple moving average is $258.76 and its 200-day simple moving average is $278.38. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $101.15 billion, a PE ratio of 23.86, a P/E/G ratio of 3.32 and a beta of 0.24.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $2.96 EPS. CME Group’s revenue was up .8% on a year-over-year basis. As a group, equities analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio is presently 44.11%.

Insider Buying and Selling

In related news, Director William Shepard acquired 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Piper Sandler cut their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a report on Wednesday, July 15th. Barclays reduced their price objective on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a report on Thursday, June 18th. Finally, TD Cowen reissued a “buy” rating and issued a $292.00 target price on shares of CME Group in a research report on Thursday. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $289.75.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.